The study of genes, their functions and their interactions. This information can help identify how genes impact growth and development and how diseases form, which can lead to new methods for disease diagnoses, treatment and prevention.
As the most common serious neurological condition in the U.S., epilepsy affects roughly 3.4 million Americans. It's what drives biopharmaceutical researchers to fight back with innovative medicines like targeted treatments that could transform the lives of patients living with the disease.
In the United States, 16 diseases are now preventable as a result of childhood vaccines, resulting in an estimated $1.4 trillion in societal costs saved.
At a recent event held by The Atlantic, scientists and researchers joined others in the biopharmaceutical industry to discuss genomics' ever-evolving and critically important role in treating disease.
Experts come together for a dialogue focused on the future of genomics, and specifically how genetic mapping will continue to empower leading scientific minds to discover breakthrough treatments.